MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company Psychedelics Investing
Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma Biotech Investing
HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility Biotech Investing
European Medicines Agency Accepts Pfizer's Marketing Authorization Application for Its Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age or Older Pharmaceutical Investing
EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency Pharmaceutical Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Biotech Investing
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
